Medical implants are increasingly often inserted into bone of frail patients, who are advanced in years. Due to age, severe trauma or pathology-related bone changes, osseous healing at the implant site is frequently limited. We were able to demonstrate that coating of endosseous implants with nanocrystalline diamond (NCD) allows stable functionalization by means of physisorption with BMP-2. Strong physisorption was shown to be directly related to the unique properties of NCD, and BMP-2 in its active form interacted strongest when NCD was oxygen-terminated. The binding of the protein was monitored under physiological conditions by single molecule force spectroscopy, and the respective adsorption energies were further substantiated by force-field-calculations.
Introduction
Only recently, the exceptional properties of diamond have been recognized to be not only of advantage in tool industry or tribology, but more than that it may also lead to improving advances when applied in life science, sensor technology or electronics. The deposition of thin films of nanocrystalline diamond (NCD) onto materials leaves the overall texture of specimen greatly unchanged while allocating a variety of properties of natural diamond to the substrate surface. Yet due to the nanotopography of NCD, the resulting surface is enlarged and in combination with further refinement, such as the termination of the dangling bonds of the carbon atoms, proliferation and differentiation of cells can be influenced in a controlled manner [1, 2] . Because the NCD surface is open to additional complex chemical refinement, it became conceivable for us to design medical implants that allow stable binding of molecules, such as bone morphogenetic protein-2 (BMP-2) [3, 4] . BMP-2 is capable of ectopic bone formation and has been approved for clinical use [5, 6] . In physiological settings, BMP-2 exerts its effects in nanogram doses [7] , yet due to release from its site of application the recommended amounts applied to date are around 25 mg depending on the respective therapeutic regimen [5, 6] . Taking this into account and in order to prolong the effect of freely-diffusible growth factors, slow releasing systems have been put to test [8] [9] [10] . This way of practice however still incurs the risk of adverse effects, which in particular may affect the vascular system [11] or the immune system [12] . In an attempt to overcome these limitations we could demonstrate only recently that BMP-2 binds to oxygen-terminated NCD (O-NCD) in a highly stable, non-covalent manner, a procedure also known as physisorption [3] . In the present investigation we further corroborated these findings by performing detailed analytical measurements using atomic force microscopy (AFM). Moreover, by carrying out in depth theoretical modeling, we attempted to apprehend the nature of the protein-NCD interaction at the atomic level. The effect of BMP-2 physisorbed to H-or O-terminated NCD was further tested in vivo by inserting implants into sheep calvaria. In order to extend our results from the animal experiment to the human system, we finally studied the osteogenic differentiation potential of primary human mesenchymal stromal cells grown on BMP-2 treated O-NCD covered implant surfaces as a substrate. The results presented in this contribution greatly suggest that this novel technique may be safely adopted for routine clinical therapies in the near future.
Material and Methods:
Theoretical calculation:
The three-dimensional structure of the BMP-2 homo-dimer [13] together with diamond as used in the present study was inapplicable as an input for quantum mechanical methods such as Density Functional Theory. Therefore, methods of classical molecular mechanics based on parameterized force fields were applied to overcome the problems with the size restrictions of quantum mechanical methods. The applied NCD-films show mainly (111) and (100) surface planes examined with xray diffraction. Reactivity of the (111) and (100) planes are known to behave equivalent with regard to adsorption. Theoretical calculations have shown that the bulk-diamond (100) surface is ideal to use for the present type of investigation [14] . Working along these lines and taking into account empirical data for molecules in isolation structural determinants at the atomic level were approximated resulting in simulations of thousands of atoms over nanoseconds of time and reliable predictions of a variety of physical properties. The ab initio force field (COMPASS (Condensedphase Optimized Molecular Potentials for Atomistic Simulation Studies; Accelrys, Inc., San Diego, USA)) was applied for an accurate and simultaneous prediction of structural properties for a broad range of molecules in isolation and in condensed phases as well as under a wide range of conditions of temperature and pressure was applied. The atomic charges were force field assigned in calculations with ultra-fine nm, respectively.
The summation method was atom based. Because the surface of many medical implants is composed of pure titanium or TiO2. and secondly in order to outline any qualitative effect taking place upon binding, the interaction of a BMP-2 homo-dimer with titanium, anatase and rutile in its (001) plane was modeled first. O-NCD was expected to be superior to H-NCD [3] , in particular with regard to BMP-2 surface bond strength at higher temperatures as well as for various surface concentrations of OH, and because the BMP-2/surface bond strength at room temperature and/or interfacial geometry will follow the calculated trend of bond energy, the calculations were performed at zero Kelvin, thus omitting the temperature dependent part (entropy, ΔS) of the free energy, ΔG:
leading to the following interaction energy as base for the theoretical calculation:
where H surface-dimer , H surface and H dimer are the energies for the total complex and the reactants prior to the attachments. The interaction energy, ΔH, was divided into different terms depending on the type of bonding between the diamond surface and the BMP-2 homo-dimer: van der Waals (including H-bonds) and electrostatic energies.
Preparation of the heteroepitaxial (001) diamond layer:
Deposition of epitaxially oriented diamond grains on a silicon (001) single crystal substrate was done in a microwave plasma chemical vapor deposition (CVD) setup at a substrate temperature of 780°C, a microwave power of 1300 W and a gas pressure of 45 mbar. Oriented nucleation was induced by the bias enhanced nucleation procedure applying a negative voltage of -210 V to the silicon substrate for 5 minutes in a gas mixture of 9% methane in hydrogen. During 18 hours growth, the process gas contained 7.5% methane and 1.25% carbon dioxide in hydrogen. The diamond surface was terminated with oxygen by thermal post-processing at 400°C for 4 hours with 21%
oxygen.
Preparation of nanocrystalline diamond (NCD) surfaces:
Deposition of randomly oriented NCD films (500 to 800 nm thick and grain sizes of 5 to 20 nm) on titanium dental implants (length: 6 mm, diameter: 4.8 mm, surface topography:
sandblasted, large grit and acid-etched (SLA) Straumann AG, Basel, Switzerland) was carried out as described recently [1] . The precursor gas was 3% methane in hydrogen.
Nucleation was induced by ultrasonic mechanical seeding procedure. Eventually, the dangling bonds at the highly hydrophobic native NCD-surface (H-NCD) with a contact angle of ~120° were terminated with oxygen by thermal post-processing at 400°C for 4 hours with 21% oxygen, rendering the NCD-surface hydrophilic (O-NCD) (contact angles < 10°).
Physisorption of BMP-2:
BMP-2 (human, E.coli expressed, R&D, Minneapolis, USA) was dissolved in deionised water following the manufacturer's recommendation. NCD-coated substrates (heteroepitaxial diamond (001)) were incubated with BMP-2 (1 µg/mL) for 90 minutes in a humidified chamber. Subsequently, treated substrates were carefully rinsed with de-ionised water or phosphate-buffered saline (PBS).
AFM imaging:
Topographical images were acquired with the aid of a Pico Plus AFM equipped with a 
AFM force spectroscopy:
The effective binding force of BMP-2 under physiologic conditions with respect to HNCD and O-NCD surfaces was quantitatively assessed using single molecule force spectroscopy. BMP-2 was tethered to amino-functionalized silicon nitride AFM tips with a force-constant of 0.03 N/m (Veeco, Dourdan, France) via aldehyde-polyethylenglycol-N-hydroxysuccinimide as described previously [15] . The AFM tip with PEG-linked BMP-2 was approached and subsequently retracted with a velocity of 300 nm/s, and the deflection traces were recorded and transformed into force versus distance curves. As physisorption of BMP-2 is assumed being a stochastic process, statistical analysis of 1000 force-versus-distance curves on each surface (4 different positions per surface) were carried out. From each force-versusdistance curve, the unbinding force and the variance of the measuring noise (fluctuation of the baseline) were taken (as the mean and the variance) to generate a Gaussian distribution representing a single force value broadened by the intrinsic measurement noise. The experimental probability-density function was calculated by summing up the Gaussian distributions and the result was normalized with respect to the overall number of recorded curves [16] .
Surgical procedure and post operational treatment:
Six healthy, 4 year-old female sheep weighing 70 ± 5 kg were fasted overnight while having free access to water. 0.5 mg atropine was administered and anaesthesia was induced with ketamin (Ketavet Bone specimens together with the inserted implants were embedded into Technovit 9100 neu (Heraeus Kulzer, Hanau, Germany). After embedding, specimens were bisected and one half was subjected to immunohistochemical analysis, while the other half underwent cutting-grinding resulting in 3 samples per specimen. The latter preparations were subsequently stained with Toluidine Blue O and the bone-to-implant contact ratio (BICR)
as previously defined as the length of bone surface border in direct contact with the implant [5] was assessed for 15 different samples per time point and experimental group.
However, BICR was solely determined at that surface lining, which prior to healing faced the open cavity. Hence only regions of de novo bone formation at the implant surface were taken into consideration. Immuno-histochemistry was performed using anti-BMP-2
antibody (H-51, rabbit polyclonal IgG; Santa Cruz Biotechnology Inc., Santa Cruz, CA) and a HRP-labeled anti-rabbit IgG followed by ACE+ staining (DAKO, Glostrup, Denmark).
Cell Culture:
Human bone-derived primary mesenchymal stromal cells (MSC) exhibiting osteogenic differentiation potential were cultivated on O-NCD-coated titanium that had been treated with BMP-2 in a manner comparable to the medical implants. MSC were isolated from the iliac crest of systemically healthy individuals, which had been harvested for reconstructive bone surgery of defects within other areas of the body as described previously [17] . Briefly, a small biopsy of substantia spongiosa osseum, which otherwise would have been discarded based on necessary bone for molding and re-contouring prior to insertion into the recipient site was taken to further investigation under an Institutional Review
Board-approved protocol after having obtained patients' written consent. After surgery, the bone was transferred into modified eagles medium (MEM) supplemented with 20% fetal calf serum (FCS), 100 units/mL penicillin, 100 µg/mL streptomycin, for transportation from the operation theatre to the clean room at room temperature. The biopsies were fragmented and marrow cells were isolated from pieces (20-100 mm 3 ) by centrifugation
(400 x g, 1 minute). After centrifugation, the remaining pieces were treated with collagenase (2.5 mg/mL in MEM) for 2 hours at 37°C, 20% O2 and 5% CO2. Thereafter, the specimen was again centrifuged (400 x g, 1 minute). Cells were resuspended and 
Statistics
Data were statistically analysed using paired Student´s t test. Analyses were performed with SPSS (vs 15, SPSS Inc., Chicago, IL). The tests were two-sided with type 1 error probability of 0.05. Data are presented as mean values ± SD.
Results

Theoretical Calculation:
The sum of the van-der-Waals and electrostatic interactions for different titanium substrates exhibited endothermic values (>0 kJ/mol) for all these compounds in the following order of decreasing endothermicity: TiO2(anatase)>TiO2(rutile)>Ti. This indicates that a BMP-2 homo-dimer will not bind to titanium surfaces. Regarding unrefined NCD (H-NCD), and O-NCD, our model assumed that besides van-der-Waals forces and H-bonds, also electrostatic interactions between the surface and BMP-2 account for binding. Under physiological conditions a water adlayer is present at NCD surfaces, which greatly influences the surface polarity and thus its degree of hydrophilicity [18] . Given that the diamond surface is completely terminated with OH and covered by a water adlayer 
AFM imaging and force spectroscopy:
AFM imaging was applied to reveal experimental evidence about the conformational state of BMP-2 when physisorbed onto O-NCD. This was feasible, because the (001) facets of heteroepitaxially oriented diamond crystallites are rather smooth (Figure 2A ) so that single BMP-2 molecules could be clearly resolved using the AFM-technique [19] . Due to the size and morphological appearance, approximately 90 percent of the bound entities were distinguished as dimers (Figure 2 B,C) . We furthermore experienced that bound BMP-2 was not removed, when directly touched with the AFM tip, even not when single 
Osseointegration of BMP-2-treated, NCD-coated implants:
In light of these results, we evaluated NCD with and without physisorbed BMP-2 in vivo.
After three days, all wounds showed a high degree of hematoma. Using a specific antibody, which discriminates between ovine and recombinant BMP-2 in immuno-histochemical analysis, we examined both exogenous and endogenous BMP-2.
Within developing bone and in the periost, BMP-2-like reactivity was detectable in all experimental groups (Figure 4) . However, only in the case of O-NCD/BMP-covered implants, BMP-2 was also found right adjacent to the implant surface after 3 days and 1 week, presumably due to physisorbed BMP-2 delivered to these sites. One week post operation, cell numbers increased in the vicinity of those implants, which exposed SLA titanium, O-NCD as well as O-NCD/BMP and H-NCD/BMP to the wound, yet not in the case of H-NCD-coated implants. H-NCD/BMP implants performed comparable to SLA titanium or O-NCD (Figure 4 ). In the surrounding of those cells, which had migrated into the space between bone and implant, decent amounts of BMP-2 were detectable ( Figure   4 ). In the case of ONCD/BMP, not only high levels of BMP-2 were detectable in the cleft region, more than that, a higher number of putative osteoblasts were found in tight contact with the implant (Figure 4 ). These characteristic cells together with extracellular matrix (ECM) in close vicinity to the implant distinctively resembled early bone formation.
Although BMP-2 was detectable in all experimental groups, the level of BMP-2 juxtaposed to O-NCD/BMP-coated implants was remarkably high, greatly suggesting that also in vivo BMP-2 remained physisorbed to O-NCD over a prolonged period. 4 weeks post operation, new bone was formed at the apex of the implant in all groups. BMP-2 levels at implantation sites were comparable to those of the surrounding osseous tissue.
One week post operation and Toluidine Blue O staining, in all specimens no gross histological differences were evident at sites of newly forming bone. However 4 weeks post operation, clear anatomical differences at the apical surface of the implant became apparent. Parts of the surface of SLA titanium, H-NCD and H-NCD/BMP were covered with accumulating fibrous tissue, whereas in the case of O-NCD/BMP, the implant was overlaid with a thick layer of mineralized osseous tissue ( Figure 5 ). To rate the efficacy of de novo bone formation at the implant surface, the bone-implant-contact-ratio (BICR) was assessed (see graph depicted in Figure 6 A). When comparing O-NCD to SLA titanium implants as a control, BICR was increased, and it was even higher in the case of O-NCD/BMP. For H-NCD implants both with and without BMP-2, BICR was decreased.
However, we also recognized that more bone mass was formed adjacent to O-NCD/BMP covered implants (Figure 6 B) .
Osteogenic induction of human mesenchymal stromal cells:
After 7 This is indicative for BMP-2 remaining tightly bound to ONCD and after physisorption, if at all, only a minor amount appears to be freely diffusible in its active form. Interestingly however, MSC cultured on plastic adjacent to the O-NCD-coated substrate, which had been physisorbed with 1.5 µg/mL BMP-2, showed an increase in SPP-1 expression. This effect might be due to excessive BMP-2, which became released from the surface after initial physisorption.
Discussion:
Endosseous implants are widely used because they effectively support the functional and aesthetic rehabilitation in orthopaedics and maxillo-facial surgery. Although most implant types have been applied in several areas with high efficacy, the surface properties of endosseous implants were continuously improved over the last years in order to optimize healing performance as well as endurance within the patient's body. In this context it is important to point out that the patients' mean age, when receiving endosseous implants constantly increased during the previous years and for that reason, poor implant site conditions, which in many cases are due to age-associated bone changes became a more prevalent problem for therapeutic strategies [20] . Growth factors such as members of the BMP family are being applied in the clinics, in particular to improve bone healing in problematic trauma cases [5, 6, 21] as well as in reconstructive surgery [22] . Due to the fact that these growth factors are still administered in a rather crude fashion, the recommended dosages are far higher from those considered to be present under normal physiological conditions. Thus as a consequence unwanted systemic effects are possible [12] . These emerging problems can only be overcome by refining the method of application, e.g. by immobilizing drugs in cases where implants are used. Potential immobilization techniques are covalent binding or adsorption [9, [23] [24] [25] [26] . Both techniques however exhibit considerable obstacles in a clinical setting. Covalent binding without complex chemistry in various sequential steps of protection and deprotection, which favor growth factor binding and minimize protein-protein crosslinking is hard to achieve by those who prepare for or perform surgery [24] . Alternatively, proteins may be immobilized to the surface of implants by adsorption. To date, many implant types are made of titanium or related alloys. These materials however exhibit only low to no protein adsorptive properties [9, 24] . A simple solution to this problem could be structural refinement or coating of the surface with a layer of biocompatible material, which also binds biomolecules tightly. In line with this, we have only recently demonstrated that BMP-2 tightly binds to O-terminated NCD and physisorbed BMP-2 remains bioactive [3] . As assumed in this contribution, it appears likely that binding of BMP-2 to NCD preferentially occurs in an energetically minimized state, which concomitantly would not alter the protein's conformation. Opposed to that, no favorable interactions could be observed in the case of titanium both when performing modeling or physical assessments of interaction forces. This is in accordance with a report that certain nano-biomaterials do exhibit surface properties that support protein binding and more than that, could also be applied to sustain particular biological functions of cells [27] . Proteins may unfold when adsorbed on nanostructures compared to microstructures [28] . Adsorption to nano-biomaterials is firstly determined by a greatly enlarged surface-to-volume-ratio, which secondly specifies surface energy [26] . In the case of NCD, surface energy is furthermore established by exposition of defined characteristics of its termination, which in due course effectuates the adsorptive properties of the material. This issue can be addressed by modeling and employing theoretical calculations. For O-NCD, we observed that van-der-Waals forces, H-bonds and electrostatic interactions contribute to the accumulating binding forces. As a consequence, BMP-2 exhibits stronger binding energies on O-NCD compared to H-NCD.
Binding of biomolecules most often takes place in an aqueous environment, thus the effect of an water adlayer was included into the present calculations. Moreover, functionalized NCD surfaces appear to strongly bind water molecules. BMP-2 binding towards H-and O-terminated surfaces was therefore calculated in conjunction of a stable water adlayer present at the surface [28] , and taking this into account, for BMP-2 on OH-terminated diamond the binding energies of -859 kJ/mol were estimated. Binding of BMP-2 when adsorbed on OH-terminated diamond can therefore be regarded as strong as if BMP-2 would have been attached in a covalent fashion. These considerations could be confirmed by means of AFM. The unbinding forces together with the overall binding probabilities of physisorbed BMP-2 on O-NCD were significantly higher compared to H-NCD. A conclusive proof of whether BMP-2, when being physisorbed to NCD is still capable of inducing ectopic bone formation is only offered by performing in vivo animal experiments [29] [30] [31] . Still it is poorly understood whether ECM acts as a buffer and due to slow release of BMP-2 a chemotactic gradient is being established, or whether cells solely respond to BMP, which is bound to components of the ECM and therefore is being presented in a complexed fashion to the corresponding surface receptor molecules [30] .
This in mind, NCD-coated titanium was physisorbed with BMP-2 prior to engraftment into freshly injured bone. Intentionally, the apical site of the implant was not brought in direct contact with bone. Thereafter the effect of differently refined NCD with or without bound BMP-2 with respect to induction of bone formation was assessed. Notably, since physisorption was carried out with 1 µg/mL BMP-2, only sub microgram amounts of the growth factor were eventually introduced into the wound. This is in sharp contrast to the extent applied in the current clinical approaches.
One week after insertion, BMP-2 appeared to be solely present at those implant surfaces As a first step in an attempt to translate these findings into a clinical application, we employed human primary MSC, which had been derived from bone of healthy individuals.
In vitro these cells firmly attach to the surface of cell culture plastic, and there grown as a monolayer, MSCs can be efficiently induced by bioactive factors, e.g. BMP-2 to commence differentiation into osteoblasts. These particular cellular derivatives of MSC express specific molecular markers and also deposit characteristic ECM components together with high levels of calcium. 
